These studies suggest that increased cofilin activity may be responsible for the cognitive and synaptic deficits associated with AD, but no direct evidence is yet available by using genetic manipulations of LIMK1/cofilin signaling. The gene discussed is CFL1; the disease is Alzheimer disease.